159 related articles for article (PubMed ID: 10588052)
1. Use of mutated PDR3 gene as a dominant selectable marker in transformation of prototrophic yeast strains.
Lacková D; Subík J
Folia Microbiol (Praha); 1999; 44(2):171-6. PubMed ID: 10588052
[TBL] [Abstract][Full Text] [Related]
2. Clustered amino acid substitutions in the yeast transcription regulator Pdr3p increase pleiotropic drug resistance and identify a new central regulatory domain.
Nourani A; Papajova D; Delahodde A; Jacq C; Subik J
Mol Gen Genet; 1997 Oct; 256(4):397-405. PubMed ID: 9393437
[TBL] [Abstract][Full Text] [Related]
3. Isolation and molecular characterization of the carboxy-terminal pdr3 mutants in Saccharomyces cerevisiae.
Simonics T; Kozovska Z; Michalkova-Papajova D; Delahodde A; Jacq C; Subik J
Curr Genet; 2000 Dec; 38(5):248-55. PubMed ID: 11191208
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-function pdr3 mutations convert the Pdr3p transcription activator to a protein suppressing multidrug resistance in Saccharomyces cerevisiae.
Sidorova M; Drobna E; Dzugasova V; Hikkel I; Subik J
FEMS Yeast Res; 2007 Mar; 7(2):254-64. PubMed ID: 17266731
[TBL] [Abstract][Full Text] [Related]
5. The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3.
Mahé Y; Parle-McDermott A; Nourani A; Delahodde A; Lamprecht A; Kuchler K
Mol Microbiol; 1996 Apr; 20(1):109-17. PubMed ID: 8861209
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance as a dominant molecular marker in transformation of wine yeast.
Kozovska Z; Maraz A; Magyar I; Subik J
J Biotechnol; 2001 Dec; 92(1):27-35. PubMed ID: 11604170
[TBL] [Abstract][Full Text] [Related]
7. Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae.
Katzmann DJ; Hallstrom TC; Voet M; Wysock W; Golin J; Volckaert G; Moye-Rowley WS
Mol Cell Biol; 1995 Dec; 15(12):6875-83. PubMed ID: 8524254
[TBL] [Abstract][Full Text] [Related]
8. Diazaborine resistance in the yeast Saccharomyces cerevisiae reveals a link between YAP1 and the pleiotropic drug resistance genes PDR1 and PDR3.
Wendler F; Bergler H; Prutej K; Jungwirth H; Zisser G; Kuchler K; Högenauer G
J Biol Chem; 1997 Oct; 272(43):27091-8. PubMed ID: 9341149
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis of Asp853 in Pdr3p transcriptional activator from Saccharomyces cerevisiae.
Dzugasova V; Borecka S; Batova M; Pilisiova R; Hervayova N; Subik J
Yeast; 2010 May; 27(5):277-84. PubMed ID: 20146400
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two alternative dominant selectable markers for wine yeast transformation.
Cebollero E; Gonzalez R
Appl Environ Microbiol; 2004 Dec; 70(12):7018-23. PubMed ID: 15574895
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane translocation of fluorescent-labeled phosphatidylethanolamine is controlled by transcription regulators, PDR1 and PDR3.
Kean LS; Grant AM; Angeletti C; Mahé Y; Kuchler K; Fuller RS; Nichols JW
J Cell Biol; 1997 Jul; 138(2):255-70. PubMed ID: 9230069
[TBL] [Abstract][Full Text] [Related]
12. PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon.
Delaveau T; Delahodde A; Carvajal E; Subik J; Jacq C
Mol Gen Genet; 1994 Sep; 244(5):501-11. PubMed ID: 8078477
[TBL] [Abstract][Full Text] [Related]
13. Trifluoroleucine resistance as a dominant molecular marker in transformation of strains of Saccharomyces cerevisiae isolated from wine.
Bendoni B; Cavalieri D; Casalone E; Polsinelli M; Barberio C
FEMS Microbiol Lett; 1999 Nov; 180(2):229-33. PubMed ID: 10556716
[TBL] [Abstract][Full Text] [Related]
14. Genetic transformation of industrial yeasts using an amino acid analog resistance gene as a directly selectable marker.
Shimura K; Fukuda K; Ouchi K
Enzyme Microb Technol; 1993 Oct; 15(10):874-6. PubMed ID: 7764106
[TBL] [Abstract][Full Text] [Related]
15. Role of the PDR gene network in yeast susceptibility to the antifungal antibiotic mucidin.
Michalkova-Papajova D; Obernauerova M; Subik J
Antimicrob Agents Chemother; 2000 Feb; 44(2):418-20. PubMed ID: 10639374
[TBL] [Abstract][Full Text] [Related]
16. Use of a YAP1 overexpression cassette conferring specific resistance to cerulenin and cycloheximide as an efficient selectable marker in the yeast Saccharomyces cerevisiae.
Akada R; Shimizu Y; Matsushita Y; Kawahata M; Hoshida H; Nishizawa Y
Yeast; 2002 Jan; 19(1):17-28. PubMed ID: 11754479
[TBL] [Abstract][Full Text] [Related]
17. Genetic mapping of nuclear mucidin resistance mutations in Saccharomyces cerevisiae. A new pdr locus on chromosome II.
Subik J; Ulaszewski S; Goffeau A
Curr Genet; 1986; 10(9):665-70. PubMed ID: 3329042
[TBL] [Abstract][Full Text] [Related]
18. FLR1 gene (ORF YBR008c) is required for benomyl and methotrexate resistance in Saccharomyces cerevisiae and its benomyl-induced expression is dependent on pdr3 transcriptional regulator.
Brôco N; Tenreiro S; Viegas CA; Sá-Correia I
Yeast; 1999 Nov; 15(15):1595-608. PubMed ID: 10572257
[TBL] [Abstract][Full Text] [Related]
19. Use of sulfite resistance in Saccharomyces cerevisiae as a dominant selectable marker.
Park H; Lopez NI; Bakalinsky AT
Curr Genet; 1999 Dec; 36(6):339-44. PubMed ID: 10654087
[TBL] [Abstract][Full Text] [Related]
20. Screening for effectors that modify multidrug resistance in yeast.
Kozovská Z; Subik J
Int J Antimicrob Agents; 2003 Sep; 22(3):284-90. PubMed ID: 13678836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
